IL156780A0 - Modular transfection systems - Google Patents

Modular transfection systems

Info

Publication number
IL156780A0
IL156780A0 IL15678002A IL15678002A IL156780A0 IL 156780 A0 IL156780 A0 IL 156780A0 IL 15678002 A IL15678002 A IL 15678002A IL 15678002 A IL15678002 A IL 15678002A IL 156780 A0 IL156780 A0 IL 156780A0
Authority
IL
Israel
Prior art keywords
transfection
protein
modified
present
relates
Prior art date
Application number
IL15678002A
Other languages
English (en)
Original Assignee
Amaxa Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amaxa Gmbh filed Critical Amaxa Gmbh
Publication of IL156780A0 publication Critical patent/IL156780A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/035—Fusion polypeptide containing a localisation/targetting motif containing a signal for targeting to the external surface of a cell, e.g. to the outer membrane of Gram negative bacteria, GPI- anchored eukaryote proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/09—Fusion polypeptide containing a localisation/targetting motif containing a nuclear localisation signal
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/10—Fusion polypeptide containing a localisation/targetting motif containing a tag for extracellular membrane crossing, e.g. TAT or VP22
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Fluid-Driven Valves (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Reciprocating, Oscillating Or Vibrating Motors (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL15678002A 2001-01-10 2002-01-10 Modular transfection systems IL156780A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10100996 2001-01-10
PCT/DE2002/000060 WO2002055721A2 (de) 2001-01-10 2002-01-10 Modulare transfektionssysteme auf der basis von nukleoproteinfilamenten

Publications (1)

Publication Number Publication Date
IL156780A0 true IL156780A0 (en) 2004-02-08

Family

ID=7670249

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15678002A IL156780A0 (en) 2001-01-10 2002-01-10 Modular transfection systems

Country Status (12)

Country Link
US (2) US7320859B2 (xx)
EP (1) EP1427837B1 (xx)
JP (2) JP4551058B2 (xx)
KR (1) KR100912741B1 (xx)
CN (1) CN100510087C (xx)
AT (1) ATE530659T1 (xx)
AU (1) AU2002238376B2 (xx)
CA (1) CA2434402A1 (xx)
DE (1) DE10290072D2 (xx)
IL (1) IL156780A0 (xx)
NO (1) NO20033144L (xx)
WO (1) WO2002055721A2 (xx)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005056752A2 (en) 2003-10-24 2005-06-23 Gencia Corporation Methods and compositions for delivering polynucleotides
US20090123468A1 (en) 2003-10-24 2009-05-14 Gencia Corporation Transducible polypeptides for modifying metabolism
US8507277B2 (en) 2003-10-24 2013-08-13 Gencia Corporation Nonviral vectors for delivering polynucleotides
US8062891B2 (en) 2003-10-24 2011-11-22 Gencia Corporation Nonviral vectors for delivering polynucleotides to plants
US8133733B2 (en) 2003-10-24 2012-03-13 Gencia Corporation Nonviral vectors for delivering polynucleotides to target tissues
WO2009067216A1 (en) * 2007-11-20 2009-05-28 Beth Israel Deaconess Medical Center Transfection reagent
KR200453773Y1 (ko) * 2008-07-07 2011-05-27 류선영 다용도 일회용 냅킨
EP2208778A1 (de) 2009-01-20 2010-07-21 Lonza Cologne AG Verfahren und Vorrichtung zur elektrischen Behandlung von Reaktionsräumen
EP3187585A1 (en) 2010-03-25 2017-07-05 Oregon Health&Science University Cmv glycoproteins and recombinant vectors
WO2012098260A1 (en) 2011-01-21 2012-07-26 Axiogenesis Ag A non-viral system for the generation of induced pluripotent stem (ips) cells
DK2691530T3 (en) 2011-06-10 2018-05-22 Univ Oregon Health & Science CMV GLYCOPROTEIN AND RECOMBINANT VECTORS
EP2568289A3 (en) 2011-09-12 2013-04-03 International AIDS Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
EP2586461A1 (en) 2011-10-27 2013-05-01 Christopher L. Parks Viral particles derived from an enveloped virus
EP2679596B1 (en) 2012-06-27 2017-04-12 International Aids Vaccine Initiative HIV-1 env glycoprotein variant
EP2848937A1 (en) 2013-09-05 2015-03-18 International Aids Vaccine Initiative Methods of identifying novel HIV-1 immunogens
EP2873423B1 (en) 2013-10-07 2017-05-31 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers
US10174292B2 (en) 2015-03-20 2019-01-08 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
EP3072901A1 (en) 2015-03-23 2016-09-28 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers
US9925258B2 (en) 2015-10-02 2018-03-27 International Aids Vaccine Initiative Replication-competent VSV-HIV Env vaccines
JP2020511931A (ja) * 2016-06-16 2020-04-23 オスロ ウニヴェルスィテーツスィーケフース ハーエフＯｓｌｏ Ｕｎｉｖｅｒｓｉｔｅｔｓｓｙｋｅｈｕｓ Ｈｆ 改良された遺伝子編集
US20210206814A1 (en) * 2017-10-12 2021-07-08 Mayo Foundation For Medical Education And Research Methods and materials for gene editing
WO2019219721A1 (en) 2018-05-18 2019-11-21 F. Hoffmann-La Roche Ag Targeted intracellular delivery of large nucleic acids

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4950599A (en) * 1987-01-29 1990-08-21 Wolf Bertling Method for exchanging homologous DNA sequences in a cell using polyoma encapsulated DNA fragments
US5763240A (en) * 1992-04-24 1998-06-09 Sri International In vivo homologous sequence targeting in eukaryotic cells
US5468629A (en) 1993-04-13 1995-11-21 Calhoun; Cornelia Method of promoting in vitro homologous recombination transfection in mammalian cells using the RecA protein
US5807746A (en) 1994-06-13 1998-09-15 Vanderbilt University Method for importing biologically active molecules into cells
US5948653A (en) * 1997-03-21 1999-09-07 Pati; Sushma Sequence alterations using homologous recombination
CA2358040C (en) 1999-01-08 2008-06-10 Amaxa Gmbh Use of the cell's own transport system for transferring nucleic acids across the nuclear membrane
CA2368998A1 (en) * 1999-03-31 2000-10-05 Invitrogen Corporation Delivery of functional protein sequences by translocating polypeptides
AU4657500A (en) 1999-04-21 2000-11-02 Pangene Corporation Locked nucleic acid hybrids and methods of use
DE19925052B4 (de) * 1999-06-01 2012-01-12 Alexander Cherkasky Proteinkomplexe für den zielgerichteten Transport von (Poly)Peptide und Nukleinsäuren und sequenzspezifische Integration von DNA-Vektoren

Also Published As

Publication number Publication date
ATE530659T1 (de) 2011-11-15
EP1427837A2 (de) 2004-06-16
NO20033144L (no) 2003-09-01
NO20033144D0 (no) 2003-07-09
WO2002055721B1 (de) 2004-05-27
KR100912741B1 (ko) 2009-08-18
JP4697982B2 (ja) 2011-06-08
EP1427837B1 (de) 2011-10-26
JP2008200041A (ja) 2008-09-04
WO2002055721A3 (de) 2004-04-15
JP4551058B2 (ja) 2010-09-22
KR20030074702A (ko) 2003-09-19
US7999073B2 (en) 2011-08-16
US7320859B2 (en) 2008-01-22
DE10290072D2 (de) 2003-12-18
CN1529759A (zh) 2004-09-15
CA2434402A1 (en) 2002-07-18
US20040137622A1 (en) 2004-07-15
AU2002238376B2 (en) 2007-05-10
WO2002055721A2 (de) 2002-07-18
CN100510087C (zh) 2009-07-08
JP2005505233A (ja) 2005-02-24
US20080220527A1 (en) 2008-09-11

Similar Documents

Publication Publication Date Title
IL156780A0 (en) Modular transfection systems
IL158474A0 (en) Biofunctional hydroxyapatite coatings and microspheres for in-situ drug encapsulation
CN110291198A (zh) 经修饰的指导rna
MY124853A (en) 4-amino-5-phenyl-7-cyclobutyl-pyrrolo[2,3-d]pyrimidine derivatives.
WO2006000448A3 (en) Fc-INTERFERON-BETA FUSION PROTEINS
DE60311567D1 (de) Trizyklische pyrazolderivate, verfahren zu ihrer herstellung und ihre verwendung als antitumor mittel
RU2004108061A (ru) Способ лечения онкологических заболеваний
HK1069126A1 (en) Drug microparticles
BR0316157A (pt) Derivados de 4-amino-5-fenil-7-ciclohexil-pirrolo[2,3-d]pirimidina
EP1362600A4 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING LURE AND METHOD OF USE THEREOF
ATE372346T1 (de) Von humanen proteinen, welche mit heparin reagieren, abgeleitete aminosäuresequenzen, die den transfer von substanzen von interesse in das innere von zellen und/oder zellkernen erleichtern
ATE328074T1 (de) Oligonukleotide die eine antisense-sequenz enthalten die durch eine sekondärstruktur stabilisiert sind und pharmazeutische zusammensetzungen die sie enthalten
WO2002083184A3 (en) Gene therapy with chimeric oligonucleotides delivered by a method comprising a step of iontophoresis
WO2002007774A3 (en) Methods for therapy of neurodegenerative disease of the brain
GB2350060A (en) Nucleic acid delivery
EP0763205A4 (en) NUCLEIC ACID SEQUENCES REGULATING THE EXPRESSION OF LUNG SPECIFIC GENES
TW200716749A (en) Interferon-beta gene therapy using an improved, regulated expression system
WO2000043510A3 (en) Ras activator nucleic acid molecules - guanine nucleotide releasing factor grf4, polypeptides and methods of use
WO2000017375A3 (en) Method to treat haemophilia by in vivo gene therapy with retroviral vectors
MXPA02009257A (es) Metodos y composiciones para elucidar perfiles de expresion de proteina en celulas.
DE60035504D1 (de) Verfahren für die verabreichung von heilmitteln mittels einer dextrinlösung
AU2806597A (en) Human DNase II
WO2003023031A1 (fr) Methode d'evaluation de l'efficacite d'une therapie aux acides nucleiques
WO2002010375A1 (fr) Sequence genique de tete d'origine humaine, vecteur genetique et procede d'expression dudit gene
MXPA03003199A (es) 3,4-dihidro-pirimido?11,2-a]pirimidinas y 3,4-dihidro-pirazino[1,2-a?3 pirimidinas sustituidas.